Company Quick10K Filing
Liberty Expedia
10-Q 2019-03-31 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-02-08
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-02
10-Q 2018-03-31 Filed 2018-05-02
10-K 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-01
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-03
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-03
8-K 2019-07-26
8-K 2019-06-28
8-K 2019-06-05
8-K 2019-04-15
8-K 2018-06-19
8-K 2018-05-18
8-K 2018-03-06

Liberty Expedia Financials

LEXE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Yummies (YUMM) -1.8 54% 0 0 0 0 0 0 -0
Alliancebernstein (ABLP) 0% -0.9 8% 8,555 4,398 2,578 0 713 790 -722
Liberty Expedia (LEXE) 0% 0.0 -0% 34,646 17,341 11,536 0 -148 994 8
Real Estate Associates IV (REAL4) -0.0 -32% 0 0 0 0 -0 0 -0
Apawthecary Pets (APAW) 0.8 -97% 0 0 0 0 -0 -0 -0
SKY Resort (SKYL) 0.0 -5,741% 0 0 0 0 -0 -0 -0
AEI Income & Growth Fund XXI (AEI21) -1.4 2% 11 0 0 0 0 1 -1
Fraud Protection Network (FPNI) 0% -1.4 -208% 1 2 1 0 -2 -1 2
iShares Gold Trust (IAU) -0.0 -185,563,862,900% 0 0 1,856 1,856 -0
Federal Home Loan Bank of Dallas (FHLBD) -0.1 0% 73,781 70,071 0 0 166 1,357 -153
Galenfeha (GLFH) -0% 0 0 0 0 2
Rasna Therapeutics (RASP) 0.0 -26% 5 2 0 0 -1 -1 -0
Osprey Technology (SFTW) 33.4 -0% 0 0 0 0 -0 -0 -0
CLIC Technology (CLIC) -2.2 -121% 0 2 0 0 -1 -1 1
Campbell Strategic Allocation Fund (CSAF) -1.3 14% 193 5 0 0 27 27 -35
Golden Star Resource (GLNS) 0.0 -718% 0 1 0 0 -0 -0 -0
Richmond Mutual Bancorporation (RMBI) -5.9 -0% 956 756 0 0 -2 7 -41
Toyota Motor Credit (TMCC) -0.8 1% 119,938 105,527 0 552 1,327 4,343 -3,605
DJO Finance (DJO) 0% 12.6 0% 2,012 2,866 1,204 0 1 189 2,394
Stoke Therapeutics (STOK) 14.2 -7% 239 5 0 0 -16 -16 -233

Balance Sheet ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Cash01,8512,5642,9803,3503,7663,5333,2012,7744,215
Accounts Receivable01,3451,5821,8141,8392,2572,3632,2982,1542,621
Inventory4140
PP&E578989601,0641,1481,2491,3199741,481967
Assets1,10133,98235,62036,74636,95235,76035,55433,06931,89734,646
Accounts Payable8
Long-Term Debt273,7953,7863,8994,9014,8634,8144,2944,2434,223
Liabilities42913,69015,53216,30316,21517,05817,34915,10714,38017,341
Stockholders' Equity6732,7632,7102,6852,7082,5752,5162,4412,4012,301
Income Statement ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue971,2562,2302,6463,0292,5742,9403,3312,6042,661
Cost of Revenue70284400414434
Gross Profit269721,7653,9152,544
R&D
SG&A131,4481,6111,5601,7121,7311,6971,730
Tax14-454-154-82-23-65-46-120-60
Net Income292,052-357-225123-44-27-42-15-64
Cash Flow ($MM)2016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating1261,677-4481,676812-3722,151
Cash Investing1,603-952-177-730-707777-724
Cash Financing155-43950-228-215-72425